<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Evolent Health on SoloSoft</title><link>https://www.solosoft.dev/tags/evolent-health/</link><description>Recent content in Evolent Health on SoloSoft</description><generator>Hugo</generator><language>en-us</language><atom:link href="https://www.solosoft.dev/tags/evolent-health/index.xml" rel="self" type="application/rss+xml"/><item><title>Evolent Health Q1 Earnings Call Highlights and Industry Impact</title><link>https://www.solosoft.dev/trends/2026-05-11-evolent-health-q1-earnings-call-highlights/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://www.solosoft.dev/trends/2026-05-11-evolent-health-q1-earnings-call-highlights/</guid><description>&lt;h2 id="why-should-the-tech-industry-care-about-evolent-healths-earnings"&gt;Why Should the Tech Industry Care About Evolent Health&amp;rsquo;s Earnings?&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Answer Summary: Evolent Health&amp;rsquo;s revenue growth and net income decline reflect typical growing pains of scaling value-based care, but its continued investment in AI and data analytics signals a new phase where healthcare technology shifts from &amp;ldquo;tool support&amp;rdquo; to &amp;ldquo;core driver.&amp;rdquo;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Evolent Health&amp;rsquo;s Q1 revenue reached $780 million, up 18% year-over-year, driven by client expansion in its value-based care services. However, net income was only $12 million, down from the same period last year, due to initial investments in new markets, technology platform upgrades, and M&amp;amp;A integration costs. For the tech industry, this means digital transformation in healthcare has entered deep waters—no longer just deploying software, but using data to redefine payment and care processes.&lt;/p&gt;</description></item></channel></rss>